Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wdzieczak

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Growth Factors (Chur, Switzerland)|January 1, 1993
Optimization of cell culture conditions for the evaluation of the biological activities of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro, a natural hemoregulatory factorC Grillon, M Lenfant, J Wdzieczak-Bakala
Leukemia Research|January 1, 1986
Modulation of protein expression in murine bone marrow cells following in-vivo cytosine arabinoside treatmentJ Wdzieczak-Bakala, M Lenfant, E Frindel
The Journal of Nutritional Biochemistry|November 13, 2004
Modulating role of glucose on magnesium transport in rat erythrocytesG Franck, J Wdzieczak-Bakala, J G Henrotte
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1983
Further purification of a CFU-S inhibitor: in vivo effects after cytosine arabinoside treatmentJ Wdzieczak-Bakala, M Guigon, M Lenfant, et al.
Stem Cells (Dayton, Ohio)|September 1, 1993
The molecular specificity of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of hematopoietic stem cell proliferationS Robinson, M Lenfant, J Wdzieczak-Bakala, et al.
Cell and Tissue Kinetics|May 1, 1985
Cyclic AMP response to various haemopoietic regulatorsJ Wdzieczak-Bakala, M Pines, M Guigon, et al.
Leukemia|March 1, 1991
Human placental low molecular weight factors inhibit the entry into cell cycle of murine pluripotent stem cellsM Lopez, J Wdzieczak-Bakala, P Pradelles, et al.
Stem Cells (Dayton, Ohio)|January 1, 1997
Inhibitory action of the peptide AcSDKP on the proliferative state of hematopoietic stem cells in the presence of captopril but not lisinoprilJ E Chisi, J Wdzieczak-Bakala, A C Riches
Cell and Tissue Kinetics|January 1, 1984
A convenient source of CFU-s inhibitors: the fetal calf liverM Guigon, J Wdzieczak-Bakala, J Y Mary, et al.
Cell and Tissue Kinetics|March 1, 1990
In vivo effect of the tetrapeptide, N-acetyl-Ser-Asp-Lys-Pro, on the G1-S transition of rat hepatocytesM N Lombard, D Sotty, J Wdzieczak-Bakala, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Growth Factors (Chur, Switzerland)|January 1, 1993
Optimization of cell culture conditions for the evaluation of the biological activities of the tetrapeptide N-Acetyl-Ser-Asp-Lys-Pro, a natural hemoregulatory factorC Grillon, M Lenfant, J Wdzieczak-Bakala
Leukemia Research|January 1, 1986
Modulation of protein expression in murine bone marrow cells following in-vivo cytosine arabinoside treatmentJ Wdzieczak-Bakala, M Lenfant, E Frindel
The Journal of Nutritional Biochemistry|November 13, 2004
Modulating role of glucose on magnesium transport in rat erythrocytesG Franck, J Wdzieczak-Bakala, J G Henrotte
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1983
Further purification of a CFU-S inhibitor: in vivo effects after cytosine arabinoside treatmentJ Wdzieczak-Bakala, M Guigon, M Lenfant, et al.
Stem Cells (Dayton, Ohio)|September 1, 1993
The molecular specificity of action of the tetrapeptide acetyl-N-Ser-Asp-Lys-Pro (AcSDKP) in the control of hematopoietic stem cell proliferationS Robinson, M Lenfant, J Wdzieczak-Bakala, et al.
Cell and Tissue Kinetics|May 1, 1985
Cyclic AMP response to various haemopoietic regulatorsJ Wdzieczak-Bakala, M Pines, M Guigon, et al.
Leukemia|March 1, 1991
Human placental low molecular weight factors inhibit the entry into cell cycle of murine pluripotent stem cellsM Lopez, J Wdzieczak-Bakala, P Pradelles, et al.
Stem Cells (Dayton, Ohio)|January 1, 1997
Inhibitory action of the peptide AcSDKP on the proliferative state of hematopoietic stem cells in the presence of captopril but not lisinoprilJ E Chisi, J Wdzieczak-Bakala, A C Riches
Cell and Tissue Kinetics|January 1, 1984
A convenient source of CFU-s inhibitors: the fetal calf liverM Guigon, J Wdzieczak-Bakala, J Y Mary, et al.
Cell and Tissue Kinetics|March 1, 1990
In vivo effect of the tetrapeptide, N-acetyl-Ser-Asp-Lys-Pro, on the G1-S transition of rat hepatocytesM N Lombard, D Sotty, J Wdzieczak-Bakala, et al.
Pageof 4